For developing the COVID Collaboration Platform to bring disparate research teams working on the same clinical research questions together to share protocols, data, and evidence. Outside of a few centrally organized trials, most COVID-19 randomized clinical trials are small and/or redundant-and it's only by aggregating evidence across these trials that we will learn how to best treat COVID-19.

  • Funded by Emergent Ventures Fast Grants
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    Emergent Ventures Fast Grants
  • Principal Investigator

    Dr. Elizabeth L Ogburn
  • Research Location

    United States of America
  • Lead Research Institution

    Johns Hopkins Hospital
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

For developing the COVID Collaboration Platform to bring disparate research teams working on the same clinical research questions together to share protocols, data, and evidence. Outside of a few centrally organized trials, most COVID-19 randomized clinical trials are small and/or redundant-and it's only by aggregating evidence across these trials that we will learn how to best treat COVID-19.